Company / Current Assets
Compass Therapeutics, Inc. Current Assets History
FY2018-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Assets
$132.8M
FY2024
5-year range
$50.2M / $194.8M
FY2020-FY2024
Trend
-13.7%
vs FY2023
Sector context
#201 of 213
Health Care
What the data says
Among 213 Health Care companies, Compass Therapeutics, Inc. is in the bottom 6% for current assets. Declined from $195M to $133M over the past 2 years.
Based on SEC 10-K filings.
$133M in FY2024 with a 5-year CAGR of +38.3%.
Declined from $195M to $133M over the past 2 years.
Health Care sector context is included.
Current Assets over time
Growth rates
- 3-Year CAGR
- -3.4%
- 5-Year CAGR
- +38.3%
- 10-Year CAGR
- -
Sector benchmark
Bottom 6% in Health CareTop 94% of 213This company $132.8M Sector average $2.5B
▼
-94.7% below sector average
Key checks
Key Insights
- 5-year CAGR of +38.3%, indicating consistent growth.
- In FY2024, current assets decreased 13.7% year-over-year.
- Ranks #201 out of 213 companies in the Health Care sector.
- Peak current assets was recorded in FY2022.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Current AssetsValue | YoY GrowthYoY |
|---|---|---|
| FY2024 | $132.8M | -13.7% |
| FY2023 | $153.9M | -21.0% |
| FY2022 | $194.8M | +32.4% |
| FY2021 | $147.1M | +193.0% |
| FY2020 | $50.2M | +91.3% |
| FY2019 | $26.2M | +104951900.0% |
| FY2018 | $25 | - |
As of FY2024 · SEC 10-K · Updated Feb 28, 2026